Research Study List

Research Staff Directory:  Our team is available to answer your questions about our services and next steps.

Open Recruiting Trials

  • Title: A Randomized Phase III Clinical Trial Evaluating Post Mastectomy Chestwall and Regional Nodal XRT and Post Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy
    Trial ID: B-51/R 1304
  • Title: A Prospective Evaluation of Movement monitoring in Pediatric Neurology
    Trial ID: Pediatric Gait
  • Title: Normal Range Values for Thromboelastography in Healthy Pregnant Volunteers
    Trial ID: TEG
  • Title: Analysis of Both Sex and Device Specific FactorRs on Outcomes in PAtients with Non-Ischemic Cardiomyopathy
    Trial ID: Bio Libra
  • Title: Blood Sample Collection Evaluate Biomarkers in Subjects with Untreated Solid Tumors
    Trial ID: Exact Sciences-2018-01
  • Title: ToRsemide comparison with furosemide FOR Management of Heart Failure
  • Title: Use of a Clinical Trial Screening Tool to Address Cancer Health Disparities in the NCI Community Oncology Research Program (NCORP)
    Trial ID: DCP-001
  • Title: Prospective Study to Collect Human Specimens for Future Scientific and Medical Research
    Trial ID: CBIO
  • Title: Phase III IGRT and SBRT vs IGRT and Hypofractionated IMRT for Localized Intermediate Risk Prostate Cancer
    Trial ID: GU005
  • Title: A Phase IIR/III Trial of Standard of Care Therapy with or Without Stereotactic Body Radiotherapy (SBRT) and/or Surgical Ablation for Newly Oligometastatic Breast Cancer
    Trial ID: NRG-BR002
  • Title: Increasing the Dose of Survivorship Care Planning in Prostate Cancer Survivors Who Receive Androgen Deprivation Therapy
    Trial ID: NRG- CC007CD
  • Title: Maintenance Systemic Therapy versus Consolidative Stereotactic Body Radiation Therapy (SBRT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancr NSCLC): A Randomized Phase II/III Trial
    Trial ID: NRG-LU002
  • Title: Randomized Trial of Standard Chemotherapy Alone or Combined with Atezolizumab as Adjuvant Therapy for Patients with Stage III Colon Cancer and Deficient DNA Mismatch Repair
    Trial ID: ATOMIC: Adjuvant Trial of Deficient Mismatch Repair in Colon Cancer
  • Title: A Prospective Controlled Evaluation of Testing Movement Monitoring in Various Clinical Groups
    Trial ID: Gait
  • Title: A blind prospective study of the performance of HE4 to predict recurrence in patients with advanced ovarian cancer, peritoneal carcinoma and tubal carcinoma
    Trial ID: FDI-78
  • Title: A Randomized Phase II/III Study of the Combination of Cediranib and Olaparib Compared to Cediranib or Olaparib Alone, or Standard of Care Chemotherapy in Women with Recurrent Platinum-Resistant or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (COCOS) IND# 124225
    Trial ID: GY005
  • Title: Reliability of Point of Care Pre-Hospital Ultrasound Interpretation in Patients Experiencing Traumatic Injuries
    Trial ID: Reliability of Point of Care Pre-Hospital Ultrasound Interpretation in Patients Experiencing Traumatic Injuries
  • Title: Repository of Phase Signals for Pulmonary Hypertension Algorithm Development
    Trial ID: PHDEV
  • Title: Phase Signal Acquisition (PSAQ): Building a Repository of Cardiac Phase Signals for Algorithm Development Recruiting Mostly Female Subjects (CADFEM)
    Trial ID: CADFEM
  • Title: Can We Be FASTeR? A Multicenter Study Utilizing Right Sided Roll to Improve Sensitivity of the FAST Examination
    Trial ID: Can We Be FASTeR?
  • Title: A Randomized Phase II/III Study of Pegylated Liposomal Doxorubicin and Atezolizumab versus Pegylated Liposomal Doxorubicin/Bevacizumab and Atezolizumab versus Pegylated Liposomal Doxorubicin/Bevacizumab in Platinum Resistant Ovarian Cancer
    Trial ID: GY009
  • Title: Apixaban For the Reduction of Thrombo-Embolism In Patients with Device-Detected Sub-Clinical Atrial Fibrillation
    Trial ID: ARTESiA
  • Title: Care Optimization Through Patient and Hospital Engagement for Heart Failure
    Trial ID: CONNECT-HF
  • Title: A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to axillary Radiation in Breast Patients (cT1-3N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy
    Trial ID: A011202
  • Title: A Phase II, Double-Blinded, Placebo-Controlled Randomized Trial of Salvage Radiotherapy with or without Enhanced Anti-Androgen Therapy with Apalutamide in Recurrent Prostate Cancer
    Trial ID: GU006
  • Title: A Multicenter Prospective Study of CA 125 and HE4 Serum Biomarkers For Monitoring The Response To First-Line Therapy In Women With Primary Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancers Excluding Ovarian Tumors Of Low Malignant Potential
    Trial ID: FDI-79

Closed Active Trials